Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD): Complete Statistical AnalysisIndependent statistical analysis of Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- guardian™ 3Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Previously Treated Male Children With Haemophilia A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- guardian™1Independent statistical analysis of Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00840086).
- GUIDEIndependent statistical analysis of Guidance of Ultrasound in Intensive Care to Direct Euvolemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03938038).
- GUIDE-ITIndependent statistical analysis of Guiding Evidence Based Therapy Using Biomarker Intensified Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01685840).
- GUIDEDIndependent statistical analysis of Genomics Used to Improve DEpression Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02109939).
- GuidePathIndependent statistical analysis of Study of Diagnostic Performance of [18F]CTT1057 in BCR: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04838613).
- GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery: Complete Statistical AnalysisIndependent statistical analysis of GUIDOR® Growth Factor Enhanced Bone Graft Substitute for the Treatment of Periodontal Defects 6-months Post-Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Gulf War Digestive Health Study: Complete Statistical AnalysisIndependent statistical analysis of Gulf War Digestive Health Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680836).
- Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP): Complete Statistical AnalysisIndependent statistical analysis of Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03975153).
- gustinpropIndependent statistical analysis of Gustin Gene Polymorphism and 6-n-propylthiouracil (PROP) Taste: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01097915).
- Gut Decontamination In Pediatric Allogeneic Hematopoietic: Complete Statistical AnalysisIndependent statistical analysis of Gut Decontamination In Pediatric Allogeneic Hematopoietic: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02641236).
- Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Gut Microbiome & Gastrointestinal Toxicities as Determinants of Response to Neoadjuvant Chemo for Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Gut Organoid and Microbiome Interactions in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Gut Organoid and Microbiome Interactions in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04497727).
- GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- GVHD ASEDIndependent statistical analysis of A Randomized, Controlled, Double-Masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-Host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients: primary endpoint results,…
- GWIndependent statistical analysis of Neoadjuvant GW572016 to Treat Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00206427).
- GWIIRTIndependent statistical analysis of Gulf War Illness Inflammation Reduction Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506192).
- GWINISIndependent statistical analysis of Gulf War Illness Nasal Irrigation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01700725).
- GWMD09126Independent statistical analysis of Treatment on Iatrogenic Weight Gain and Dyslipidaemia Associated With Olanzapine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01491490).
- GWPCARE5Independent statistical analysis of An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects: Complete Statistical AnalysisIndependent statistical analysis of Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00937950).
- Gynecological Sentinel Lymph Nodes CEUS: Complete Statistical AnalysisIndependent statistical analysis of Gynecological Sentinel Lymph Nodes CEUS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05105087).
- H2HIndependent statistical analysis of Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- H2H-DFUIndependent statistical analysis of MIRODERM H2H DFU Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03232333).
- H2SPharmIndependent statistical analysis of Peripheral Vascular Effects of Sulfhydryl-containing Antihypertensive Pharmacotherapy on Microvessels in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- H3MIndependent statistical analysis of Healthy Hearts Healthy Minds: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03373110).
- H3N2 M2SR in Pediatric Population: Complete Statistical AnalysisIndependent statistical analysis of H3N2 M2SR in Pediatric Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03553940).
- H42/H4UIndependent statistical analysis of Pragmatic Randomized Clinical Trial to Limit Weight Gain in Pregnancy and Prevent Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses: Complete Statistical AnalysisIndependent statistical analysis of H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HA vs PRPIndependent statistical analysis of Hyaluronic Acid vs Platelet Rich Plasma: Effects on Clinical Outcomes and Intra-articular Biology for the Treatment of Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size…
- HABITSIndependent statistical analysis of Healthy Homes, Healthy Habits: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03433456).
- HAHPSIndependent statistical analysis of Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HAI115879Independent statistical analysis of Dose Ranging of GSK2336805 in Combination Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01648140).
- Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece: Complete Statistical AnalysisIndependent statistical analysis of Hair Count Reduction Verification Study With the LightSheer Duet HS Handpiece: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Haiti Community Health Workers (CHW) Adaptation: Complete Statistical AnalysisIndependent statistical analysis of Haiti Community Health Workers (CHW) Adaptation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05091710).
- HALOIndependent statistical analysis of A Study of CIN-107 in Patients With Uncontrolled Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05137002).
- HALO Patient Registry: Ablation of Barrett’s Esophagus: Complete Statistical AnalysisIndependent statistical analysis of HALO Patient Registry: Ablation of Barrett's Esophagus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00848237).
- HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).
- HALT-DIndependent statistical analysis of Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HAMIndependent statistical analysis of Sleep Length and Circadian Regulation in Humans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00843843).
- Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Hand-carried Ultrasound to Assess Hydronephrosis: Complete Statistical AnalysisIndependent statistical analysis of Hand-carried Ultrasound to Assess Hydronephrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03774719).
- Handgrip Exercise for Arteriovenous Fistula Maturation: Complete Statistical AnalysisIndependent statistical analysis of Handgrip Exercise for Arteriovenous Fistula Maturation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01061008).
- Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: Complete Statistical AnalysisIndependent statistical analysis of Handheld Ultrasound Evaluation of the Inferior Vena Cava to Guide Heart Failure Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- HANDmacIndependent statistical analysis of A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- HAPIIndependent statistical analysis of HIV And Parasitic Infection (HAPI) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05323396).
- Haplo/CordIndependent statistical analysis of Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells: Complete Statistical AnalysisIndependent statistical analysis of Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01050764).